Nuvation Bio Inc. (NUVB) stock
NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30101% above fair value
$3.78−0.12 (-3.08%)
Close on Nov 18, 2026Market cap $1.33BP/E –Yield –
Nuvation Bio shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Nuvation Bio's shares outstanding was 0M at Jun 30, 2026. For fiscal 2025 it was 0M, up 27.1% from the year before. The highest annual figure on record is 98M in fiscal 2020.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0M | +27.1% |
| FY2024 | Dec 31, 2024 | 0M | +22.8% |
| FY2023 | Dec 31, 2023 | 0M | +1.0% |
| FY2022 | Dec 31, 2022 | 0M | +9.5% |
| FY2021 | Dec 31, 2021 | 0M | -99.8% |
| FY2020 | Dec 31, 2020 | 98M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 0M | +2.4% |
| Q1 FY2026 | Mar 31, 2026 | 0M | +11.5% |
| Q4 FY2025 | Dec 31, 2025 | 0M | +2.1% |
| Q3 FY2025 | Sep 30, 2025 | 0M | +25.2% |
| Q2 FY2025 | Jun 30, 2025 | 0M | +39.2% |
| Q1 FY2025 | Mar 31, 2025 | 0M | +54.6% |
| Q4 FY2024 | Dec 31, 2024 | 0M | +54.1% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +25.0% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +11.8% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +0.1% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +0.2% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +0.3% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +1.0% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +2.5% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +3.9% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +5.4% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +6.2% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +25.8% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +129.2% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +133.4% |
| Q2 FY2021 | Jun 30, 2021 | 0M | -99.8% |
| Q1 FY2021 | Mar 31, 2021 | 0M | – |
| Q3 FY2020 | Sep 30, 2020 | 0M | – |
| Q2 FY2020 | Jun 30, 2020 | 0M | – |
| Q1 FY2020 | Mar 31, 2020 | 86M | – |
See a number that looks wrong?